ArticlePulmonary circulation2022

An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension.

Marc A Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.